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Summary
Introduction:  Better  outcomes  have  been  reported  for  two-stage  total  hip  arthroplasty  (THA)
revision  for  infection.  However,  one-stage  revision  arthroplasty  remains  an  attractive  alter-
native option  since  it  requires  only  one  operation.  A  decision  tree  has  been  developed  by
the authors  in  order  to  determine  which  type  of  surgical  procedure  can  be  performed  safely.
The goal  of  this  study  was  to  assess  this  decision  tree  for  THA  replacement  in  the  case  of  a
peri-prosthetic  infection.
Hypothesis:  A  one-stage  procedure  may  be  as  successful  as  a  two-stage  procedure  provided
some criteria  are  fulﬁlled.
Methods:  A  prospective  study  included  84  patients,  all  diagnosed  with  infected  THA  who  had
prosthesis  replacement.  A  one-stage  exchange  was  performed  in  38  cases  and  a  two-stage  pro-
cedure in  46  cases.  A  two-stage  procedure  was  decided  in  the  case  of  important  bone  loss  or
unidentiﬁed  germ.  Postoperatively,  patients  received  intravenous  antibiotics  (six  weeks),  then
oral antibiotics  (six  weeks).  The  main  evaluation  criterion  was  the  rate  of  infection  eradication
at 2  years  minimal  follow-up  since  surgery.  If  new  infection  was  suspected,  a  hip  aspiration
was performed  to  determine  whether  it  was  non-eradication  (same  germ)  or  a  new  re-infection
(other germ),  which  was  not  considered  as  a  failure.
Results:  The  initial  infection  was  cured  in  83  out  of  84  patients  (98.8%),  38  (100%)  for  the
one-stage  group  and  45  (97.8%)  for  the  two-stage  group.  Three  patients  were  re-infected  with
different germs  in  the  two-stage  group.  Eighty  out  of  84  (95.2%)  patients  were  infection  free,
all patients  (100%)  of  the  one-stage  group  and  42  patients  (91.3%)  of  two-stage  group.
Discussion:  If  some  selection  cr
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Figure  1  Decision  tree.
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Introduction
Infection  after  total  hip  arthroplasty  (THA)  remains  a  severe
and  costly  complication  [1,2]. Although  the  infection  rate
after  THA  has  been  signiﬁcantly  reduced  ranging  between
0.3%  and  2.2%  [3—5], it  is  still  a  cause  for  concerns.  In
fact,  between  7%  and  16%  [6,7]  of  THA  revisions  are  car-
ried  out  for  infection  according  to  the  Scandinavian  register.
Bozic  et  al.  [8]  showed  that  14%  of  THA  revision  procedures
were  performed  for  chronic  infection  and  for  Jafari  et  al.
[9],  infection  was  the  most  common  cause  of  THA  failure
(30.2%).  Mostly,  the  control  of  the  infection  requires  remo-
ving  the  implants.  Afterwards,  the  treatment  strategy  varies
according  to  authors  with  three  different  procedures:  no
re-implantation,  immediate  placement  of  new  implants  or
a  two-stage  surgery  re-implantation  [10,11].  The  reported
success  rates  vary  from  85%  to  95%  with  better  outcomes  for
a  two-stage  surgery  comparatively  to  a  one-stage  surgery
(Elson  [12]  96.5%  vs  87.6%,  Garvin  et  al.  [13]  94.4%  vs  89.9%).
However,  the  two-stage  procedure  has  many  disad-
vantages:  patients  undergo  two  operations  with  a  higher
morbidity  risk,  longer  hospital  stay  duration  and  a  loss  in
quality  of  life  [14]. Furthermore,  the  two-stage  replacement
generates  an  increase  in  the  cost  of  about  1.7  fold  compar-
atively  to  the  one-stage  [2].  Some  authors  proposed  speciﬁc
criteria  in  order  to  select  the  patients  who  may  beneﬁt  of  a
one-stage  procedure  with  no  loss  of  chance  in  treating  the
infection  [15—18].
Our hypothesis  was  that  a  one-stage  procedure  might  be
as  successful  as  a  two-stage  procedure  if  some  criteria  are
fulﬁlled.  Based  on  our  experience,  a  decision  tree  was  devel-
oped  in  our  department  in  order  to  determine  the  type  of
surgical  management  according  to  some  criteria.  The  goal
of  this  study  was  to  evaluate  prospectively  the  rate  of  con-
trolled  infections  when  using  this  protocol  for  the  treatment
of  infected  THA  and  to  determine  whether  the  criteria  used
were  relevant.  The  results  would  be  helpful  to  determine
what  would  be  the  best  strategy  according  to  the  patient.
Materials and methods
Inclusion  and  exclusion  criteria
A  prospective  non-randomised  study  was  carried  out  in  our
department  from  September  2002  to  June  2006  and  included
all  patients  diagnosed  with  infected  hip  arthroplasty.  The
replacement  was  performed  in  patients:
•  who  had  a  good  general  health  according  to  Ameri-
can  Society  of  Anaesthesiologists  (ASA)  physical  status
classiﬁcation  [19]  allowing  surgery  and  prosthesis  re-
implantation  (ASA  1  to  3);
•  if  the  infection  duration  was  more  than  two  weeks  from
implantation;
•  or  in  the  case  of  loosening.
The  one-stage  procedure  was  performed  if  the  germ  was
known  before  exchange  and  if  the  bone  loss  was  considered
as  minor  by  the  surgeon  both  preoperatively  on  radiographs
and  peroperatively  after  components  removal,  according
to  Paprosky  classiﬁcation  [20,21].  The  bone  damage  was
f
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tonsidered  major  if  massive  cortico-cancellous  bone  graft-
ng  was  necessary  (Fig.  1).
The  inclusion  criteria  were:  a  previous  THA,  a  diag-
osis  of  infection  based  on  bacterial  identiﬁcation  in
ultures  samples  collected  by  hip  aspiration  preoperatively
r  peroperatively  and  a  written  informed  consent  for  the
erformance  of  the  study.  The  exclusion  criteria  were:
atients  non-operated  for  re-implantation  and  the  patient
efusal.  An  ethical  comity  (CPP  Ile-de-France  VI)  approved
his  study.
All  components  were  removed  in  all  the  cases.  In  the
ase  of  a two-stage  replacement,  the  second  procedure  was
arried  out  after  an  average  duration  of  six  weeks  after  the
ntibiotherapy  completion.  Between  the  two  stages  an  artic-
lated  hand  made  cement  spacer  without  antibiotics  was
sed  in  order  to  avoid  limb  shortening  and  to  allow  a  phys-
otherapy  including  hip  mobilisation  and  muscle  training.
At  least  three  staggered  deep  peroperative  samples  were
aken  for  microbiological  diagnosis  during  the  ﬁrst  stage  and
efore  re-implantation  for  the  two-stage  procedure.  Sys-
emic  antibiotics  were  given  through  a  central  venous  access
nd  afterwards  oral  antibiotics  were  indicated.  At  least  two
fﬁcient  antibiotics  were  prescribed  according  to  the  antibi-
grams  performed  on  the  cultures  samples.  For  two-stage
rocedure,  if  germs  were  found  during  the  second  stage,  a
omplementary  antibiotherapy  adapted  to  the  antibiogram
as  performed  after  re-implantation.  The  efﬁciency  and  the
olerance  of  antibiotics  were  controlled  by  calculating  their
ystemic  antibiotic  concentrations.  No  local  antibiotherapy
as  used.
During  this  period,  122  consecutive  patients  diagnosed
ith  infected  hip  arthroplasty  were  treated  in  our  depart-
ent.  Four  patients  died  before  2  years  of  follow-up
or  a  different  reason.  Among  these  118  patients,  two-
tage  replacement  was  performed  in  46  patients,  one-stage
eplacement  in  38  patients,  a  resection  or  a  coaptation  in
en  patients,  a  curative  debridement  in  nine  patients  and  a
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Table  1  Description  of  one-  and  two-stage  group.
One-Stage  Group  Two-Stage  Group  Statistic  analysis  (p)
Age 63.60  ±  14.8  66.87  ±  12.1  0.27  (NS)
Sex ratio  18F/20  M  20F/26  M  0.72  (NS)
BMI 28.3  ±  5.3  25.4  ±  4.4  0.009
Initial hip  disease  0.64  (NS)
Primary osteoarthritis 26  29
Osteonecrosis 4 3
Post traumatic 5 6
CDD 2 3
Others 1 5
Number  of  previous  surgeries  2.2  ±  1.9  3.2  ±  2.4  0.04
Preoperative  score  (Postel  Merle  d’Aubigné  [22])  11.1  ±  3.1  9.6  ±  4.2  0.07  (NS)
Acetabular  bone  loss  according  to  Paprosky  [20]  0.0001
Type I  24  (63.2%)  3  (6.5%)
Type IIA  7  (18.4%)  11  (24%)
Type IIB  5  (13.2%)  7  (15.2%)
Type IIC  1  (2.6%)  3  (6.5%)
Type IIIA  0  (0%)  19  (41.3%)
Type IIIB  1  (2.6%)  3  (6.5%)
Femoral  bone  loss  according  to  Paprosky  [21]  0.08  (NS)
Type I  15  (39.5%)  7  (15.2%)
Type II  14  (36.8%)  24  (52.2%)
Type IIIA  7  (18.4%)  13  (28.3%)
Type IIIB  2  (5.3%)  2  (4.3%)
Type IV  0  (0%)  0  (0%)
Surgical  complication  7  (18.4%)  14  (30.4%)  0.20  (NS)
Initial infection  eradication  38/38  (100%)  45/46  (97.8%)  0.36  (NS)
Patients infection  free  38/38  (100%)  42/46  (91.3%)  0.11  (NS)
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CDD: congenital developmental dysplasia.
ifetime  suppressive  antibiotics  with  or  without  a  debride-
ent  in  15  patients.
Two  deaths  were  due  to  infection:  one  patient  after
esection  and  one  after  debridement  with  a  lifetime  sup-
ressive  antibiotics.
escription  of  the  one-stage  group
hirty-eight  patients  had  a  direct  exchange  of  the  implants.
hey  were  composed  of  18  women  and  20  men  with  a  mean
ge  of  63.6  ±  14.8  years  (range,  25—90).  Two  patients  were
iabetic  and  one  patient  had  an  immunosuppressive  treat-
ent  for  psoriatic  arthritis.  Three  patients  were  classiﬁed
s  ASA  1,  31  as  ASA  2  and  four  as  ASA  3.  The  average  body
ass  index  (BMI)  was  28  ±  5  (range,  18—43),  14  patients
ere  obese  (BMI  ≥  30).  These  patients  had  previously  in
verage  2.2  ±  1.8  (range,  1—10)  surgical  procedures  of  the
nfected  hip.  The  initial  THA  was  performed  for  primary
steoarthritis  in  26  cases;  the  other  aetiologies  are  reported
n  Table  1.  Three  patients  had  a  ﬁstula.  The  mean  duration
f  infection  before  surgery  was  12  months  (from  ten  days  to
.5  years).  For  two  patients,  the  infection  duration  was  less
han  two  weeks  but  with  loosening  of  the  implants.  Before
he  revision,  the  mean  Postel-Merle-Aubigné  (PMA)  score
22]  was  11.1  ±  3.1  (range,  5—16),  the  mean  Erythrocyte
edimentation  Rate  (ESR)  was  43.4  ±  32  mm  (range,  2—100),
a
7
56  15  ±  3  0.46  (NS)
ess  than  30  for  16  patients  and  the  C-reactive  protein  (CRP)
as  about  40  ±  50  mg/L  (range,  1—223),  less  than  10  in  nine
atients.  The  bone  loss  according  to  the  Paprosky  score
20,21]  is  shown  in  Table  1.  The  most  frequent  germ  was  the
taphylococcus  spp.  (22/38);  the  other  germs  are  shown  in
ig.  2.  In  four  patients  (10.5%),  bacteria  were  multi-resistant
i.e.  sensitive  to  less  than  three  antibiotics  families).  The
ean  follow-up  for  this  group  ranged  from  24—61  with
n  average  of  35  ±  11.5  months  and  no  patient  was  lost  to
ollow-up.
The  approach  was  posterior  lateral  in  26  cases  and
nterolateral  in  12  patients.  A  trochanterotomy  was  per-
ormed  in  eight  cases.  A  femorotomy  was  performed  in  two
ases  and  nine  times  a  femoral  window  was  used  in  order
o  get  out  the  cement  plug  or  the  diaphyseal  restrictor.  A
ortico-cancellous  grafting  was  performed  on  the  acetabu-
ar  side  in  six  cases  and  an  acetabular  plate  (Kerboull  plate)
as  used  in  nine  cases  in  order  to  get  a  good  mechanical
upport.  Cemented  cups  were  implanted  in  28/38  patients.
emented  femoral  stems  were  used  in  25/38  cases.  A  stan-
ard  stem  was  used  in  30/38  cases  and  long  ones  in  eight
ases.  The  cement  used  was  not  antibiotic-loaded.Systemic  antibiotics  were  given  through  a  central  venous
ccess  for  an  average  duration  of  42  ±  12.4  days  (range,
—86)  and  afterwards  oral  antibiotics  were  given  for
1.1  ±  27.1  days  (range,  0—138).
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Figure  2  Bacteria  found  in  the  one-stage  replacement  group.
A. Staphylococcus  22  (MR  S.  epidermidis  7,  MS  S.  epidermidis  3,
GISE 2,  MS  S.  aureus  4,  MR  S.  aureus  2,  S.  capitis  2,  S.  caprae  1,
S. lugdunensis  1).  B.  anaerobic  bacteria  6  (Propionibacterium
acnes  4,  Propionibacterium  avidum  1,  Peptostreptococcus
micros  1).  C.  Streptococcus  5  (group  B  2,  others  3).  D.  polymi-
crobial  3  (1  P.  acnes  +  S.  capitis//1  P.  acnes  +  Corynebacterium
striatum//1  MR  S.  epidermidis  +  MS  S.  aureus  +  Proteus
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Figure  3  Bacteria  found  in  the  two-stage  replacement
group.  A.  Staphylococcus  29  (MR  S.  epidermidis  11,  MS
S. epidermidis  4,  GISE  3,  MS  S.  aureus  5,  MR  S.  aureus  1,
S. capitis  3,  S.  lugdunensis  1,  S.  warnerii  1).  B.  anaerobic
bacteria  7  (Propionibacterium  acnes  4,  Micrococcus  sp.  1,
Corynebacterium  2).  C:  Streptococcus  5  (group  B  3,  oth-
ers 2).  D.  polymicrobial  4  (1  Peptostreptococcus  micros  +  MS
Staphylococcus  spp.//1  MR  S.  aureus  +  Streptococcus  group
B +  Pseudomonas  aeruginosa  +  Propionibacterium  avidum//1
Clostridium  perfringens  +  Candida  glabrata//1  Staphylococcus
capitis +  Corynebacterium  macginleyi).  E.  Enterococcus  faecalis
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omirabilis  +  Enterococcus  faecalis  +  C.  striatum).  E.
Escherichia  coli  1.  F.  E.  faecalis  1.
Seven  patients  had  a  surgical  complication:  two
haematoma  which  did  not  require  a  revision,  one  false
reaming  route  detected  and  corrected  during  the  surgical
procedure,  three  early  postoperative  dislocations  and  one
recurrent  dislocation  that  required  a  revision  with  the  cup
removal  and  implantation  of  a  retentive  device.
Four  patients  presented  a  complication  due  to  the  central
venous  access:  two  catheter  infection,  one  thrombosis  and
one  pneumothorax.  Furthermore,  13  patients  (34.2%)  had  a
minor  complication  that  required  an  exchange  of  the  antibi-
otics  in  six  cases:  two  drug  interactions,  two  hypersensitivity
reactions  (mynocine),  one  cutaneous  rash  (rifampicin)  and
one  increase  of  serum  creatinin  level  (fosfomycin).
Description  of  the  two-stage  group
Forty-six  patients  had  a  two-stage  replacement  of  the
implants.  The  two-stage  replacement  were  indicated  when
there  was  lack  in  microbial  preoperative  diagnosis  in  four
patients  and  a  major  bone  loss,  especially  on  acetabular
side,  for  all  others  patients.  One  patient  was  scheduled
for  a  one-stage  procedure  but  peroperatively  bone  stock
didn’t  allow  direct  exchange.  The  two-stage  group  was
composed  of  20  women  and  26  men  with  a  mean  age  of
66.9  ±  4.2  years  (range,  45—89).  Three  patients  were  dia-
betic.  Three  patients  were  classiﬁed  as  ASA  1,  35  as  ASA  2
and  eight  as  ASA  3.  The  average  BMI  was  25.4  ±  4.9  (range,
18—38),  nine  patients  were  obese  (BMI  ≥  30).  These  patients
had  previously  3.19  ±  1.4  (range,  1—12)  surgical  procedures
on  the  infected  hip.  The  initial  THA  was  performed  for  pri-
mary  osteoarthritis  in  29  cases;  the  other  aetiologies  are
reported  in  Table  1.  Five  patients  had  a  ﬁstula.  The  mean
duration  of  infection  before  surgery  was  24  months  (from
11  days  to  12  years).  For  three  patients  the  infection  dura-
tion  was  less  than  two  weeks  but  with  loosening  of  the
implants.  Before  revision,  the  mean  Postel-Merle-Aubigné
score  [22]  was  9.6  ±  2.1  (range,  3—17),  the  mean  ESR  was
i
u
a
i.
2.3  ±  7.1  mm  (range,  2—100),  less  than  30  for  11  patients,
nd  the  CRP  was  about  65.9  ±  5.7  mg/L  (range,  2—475),
ess  than  10  in  eight  patients.  The  bone  loss  according  to
he  Paprosky  score  [20,21]  is  shown  in  Table  1.  The  most
requent  germ  was  Staphylococcus  spp.  (29/46);  the  other
erms  are  shown  in  Fig.  3.  In  seven  patients  (15.2%),  bacteria
ere  multi-resistant.  A  hip  aspiration  was  performed  before
he  second  stage  in  41/46  patients,  at  least  15  days  after
nding  administration  of  antibiotics,  but  all  these  cultures
ere  negative.  All  patients  (46/46)  had  culture  of  the  sam-
les  taken  at  the  time  of  the  second  stage.  In  17  among
6  patients,  the  culture  found  germs,  identical  to  the  ini-
ial  causal  one  in  eight  cases.  For  these  17  patients,  the
ean  duration  of  the  complementary  antibiotics  administra-
ion  was  52.9  ±  23.2  days  (range,  30—90).  The  mean  duration
etween  the  two  procedures  was  4.45  ±  0.7  months.  The
ean  follow-up  ranged  from  24  to  68  with  an  average  of
5  ±  19  months  and  no  patient  was  lost  to  follow-up.
A  posterior  lateral  approach  was  used  in  36  patients  and
n  anteriorlateral  approach  in  10  patients.  A  trochantero-
omy  was  performed  in  12  cases.  A  femorotomy  was  used
n  12  cases  in  order  to  get  out  all  the  cement  and  a  com-
lementary  femoral  corticotomy  was  required  in  11  patients
n  order  to  remove  the  plug  or  the  diaphyseal  restrictor.  A
pacer  made  with  a  Kuntcher  nail  and  a  sphere  of  cement
as  placed  during  the  ﬁrst  stage.  In  two  patients  who  had
 severe  bone  loss,  no  spacer  was  used  because  of  a  high
isk  of  spacer  dislocation.  During  the  second  stage,  a  cortic-
cancellous  grafting  was  performed  on  the  acetabular  side
n  32  cases  and  an  acetabular  plate  was  used  in  30  cases  in
rder  to  get  a  good  mechanical  support.  A  cemented  cup  was
mplanted  in  41/46  patients.  Cemented  femoral  stems  were
sed  in  29/46  cases.  A  standard  stem  was  used  in  32/42  cases
nd  long  ones  with  length  ranging  from  200  mm  to  300  mm
n  16/46  cases.
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Intravenous  antibiotics  were  given  through  a  central
enous  access  for  an  average  duration  of  47  ±  20.5  days
range,  10—90)  and  afterwards  oral  antibiotics  were  given
or  47  ±  19  days  (range,  15—78).
Complications  occurred  in  14  patients  (nine  after  the
rst  stage  and  ﬁve  after  the  second  stage).  After  the  ﬁrst
tage,  haematoma  occurred  in  four  cases,  two  patients
ad  a  femoral  fracture  that  required  an  osteosynthesis  and
our  (8.7%)  patients  presented  a  spacer  dislocation.  After
he  second  stage,  one  haematoma  and  four  dislocations
ccurred,  one  patient  had  repeated  revision  to  manage
nstability  by  means  of  a  retentive  cup.
After  the  ﬁrst  stage,  three  patients  presented  a  complica-
ion  due  to  the  central  venous  access:  two  cases  of  catheter
nfection  and  one  pneumothorax.  Furthermore,  18  patients
39%)  had  a  minor  complication  which  required  an  exchange
f  the  antibiotics  in  13  cases:  three  acute  renal  insufﬁ-
iencies  (gentamicin),  two  leuconeutropenia  (vancomycin,
ifampicin),  two  cutaneous  rash  (mynocin,  rifampicin),  two
ypersensitivity  reactions  (mynocin),  one  hepatic  cholesta-
is  (fusidic  acid),  one  severe  nausea  (rifampicin),  one
epatic  cytolysis  (rifampicin)  and  one  drug  interaction.
mong  the  17  patients  who  had  a  complementary  antibio-
herapy  after  the  second  stage,  ﬁve  patients  (29.4%)
resented  complications  related  to  the  antibiotics  require-
ent  a  modiﬁcation  of  the  treatment  for  four  patients
ethod  of  assessment
he  infection  was  considered  as  controlled  if  at  a  minimum
f  2  years  follow-up,  patients  had  no  clinical,  no  biological
nd  no  radiological  signs  of  infection  related  [23]. In  the
ase  of  suspicion  of  infection,  hip  aspiration  was  performed
nd  bacterial  identiﬁcation  was  made  with  cultures  samples
n  order  to  determine  whether  it  was  a  non-control  of  the
nitial  infection  or  a  re-infection  with  different  germs.  The
uccess  rate  was  deﬁned  as  the  percentage  of  controlled
nitial  infections  at  2  years  minimal  follow-  up.
Patients  were  analysed  preoperatively  and  at  the  last
ollow-up,  clinically  with  the  PMA  score,  and  biologically
ith  blood  tests  including  the  ESR  and  the  CRP.  Hip  X-rays
ncluding  anterior-posterior  and  lateral  views  were  per-
ormed  pre-operatively  and  at  the  last  follow  up.  No  patient
as  lost  at  follow-up.
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Table  2  Patients  who  had  a  re-infection  with  a  different  germ.
Initial  germ MR  Staphylococcus  aureus  
Age 77
Number of  previous  procedures  4  
Germ at  2nd  stage  GI  Staphylococcus
epidermidis
Germ responsible  of  re-infection  Streptococcus  lugdunensis  
Delay for  re-infection  (months)  8  
Treatment of  re-infection  Chronic  oral  antimicrobial
suppression  therapy
Last follow  up  with  controlled
infection  (months)
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tatistical  methods
istribution  of  variables  was  tested  for  normality  using  the
yan-Joiner  test.  For  normally  distributed  variables,  when
wo  groups  had  the  same  variances,  differences  between
hem  were  analysed  by  using  Student’s  t-test.  For  abnor-
ally  distributed  variables  or  normally  distributed  variables
ith  different  variances,  we  used  the  Mann  and  Whitney
est.  Chi2 test  or  Fischer  exact  was  used  to  compare  quali-
ative  parameters.  A  p  value  of  less  than  0.05  was  considered
o  be  signiﬁcant.
esults
he  initial  infection  was  not  controlled  in  one  patient  who
ad  a  two-stage  replacement.  Therefore,  the  success  rate
as  of  100%  (38  out  of  38)  in  the  one  stage  group  and  of  97.8%
45  out  of  46)  in  the  two-stage  group.  This  infection  was
nally  controlled  after  a  repeated  two-stage  replacement
ith  a  follow-up  of  24  months.
However,  three  patients  in  the  two-stage  group  had  a  re-
nfection  with  a  different  germ  (Table  2).  At  follow-up,  80
ut  of  84  (95.2%)  patients  were  infection  free,  all  patients
100%)  of  the  one-stage  group  and  42  patients  (91.3%)  of  two-
tage  group.  The  patients  with  a  re-infection  were  treated
s  follow:  a  surgical  debridement  with  prosthesis  retention
as  performed  in  one  case;  one  patient  underwent  a  one-
tage  replacement,  and  the  last  patient  had  a  chronic  oral
ntimicrobial  suppression  therapy  because  of  a  poor  general
ealth  status  that  did  not  allow  a re-implantation.  At  the
ast  follow-up  of  18.8  ±  9  months,  these  patients  remained
symptomatic  and  had  a  functional  prosthesis.
The  bone  loss  was  signiﬁcantly  more  important  in  the
wo-stage  group  as  it  was  a  selection  criterion  (Table  1).
therwise,  there  was  no  signiﬁcant  difference  between  the
wo  groups  regarding  age,  sex  ratio,  initial  hip  disease,  pre-
perative  and  postoperative  clinical  score  (Table  1).  In  the
ther  hand,  there  was  a  signiﬁcant  difference  for  BMI  that
as  higher  in  the  one-stage  group  and  the  number  of  previ-
us  hip  surgical  procedures  (p  <  0.05)  that  was  higher  in  the
wo-stage  group  (Table  1).  The  complication  rate  was  higher
n  the  two-stage  procedures  but  no  signiﬁcant.  There  was  no
igniﬁcant  difference  for  the  success  rate  between  the  two
roups.  However,  there  was  a  higher  risk  for  re-infections  in
he  two-stage  group  (0%  vs  6.5%).
Propionibacterium  acnes  MR  Staphylococcus  epidermidis
85 62
1  4
No  germ  No  germ
Citrobacter  koserii  MS  Staphylococcus  epidermidis
6  26
Debridement  One-stage  removal
replacement
33  12
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Discussion
The  main  ﬁnding  of  this  study  was  that  if  some  selection
criteria  were  respected,  a  high  success  rate  in  THA  revision
done  for  infection  might  be  achieved  with  a  one-stage  pro-
cedure,  similar  to  the  two-stage  procedures.  The  criteria
used  to  select  the  patients  who  may  beneﬁt  of  a  one-stage
procedure  were  found  to  be  relevant.
In  our  study,  the  infection  was  controlled  in  all  the
patients  treated  with  a  one-stage  procedure  giving  a  100%
success  rate.  This  ﬁnding  compares  well  to  the  results  pre-
viously  reported  by  Ure  et  al.  [15]  who  achieved  also  a  100%
success  rate  when  using  a  one-stage  procedure  in  selected
patients.  Similar  results  were  also  reported  by  Callaghan
et  al.  [16]  with  a  91.7%  success  rate.  Callaghan’s  criteria
[16]  were  quite  similar  to  ours:  no  signiﬁcant  immuno-
compromised  patient,  no  sinus  tracts,  an  adequate  bone
available  for  revision  and  an  obtainable  complete  soft  tis-
sue  and  bone  debridement.  However,  they  had  only  a  small
number  of  patients  (20  and  24)  and  their  study  was  not  com-
parative,  without  a  control  two-stage  group.  In  our  study,
ﬁstula  was  not  an  exclusion  criterion  for  one-stage  revision.
Previously,  Raut  et  al.  [18]  had  shown  that  an  actively  dis-
charging  sinus  is  not  in  itself  a  contraindication  to  one-stage
revision.
The  two-stage  procedure  replacement  of  THA  for  sepsis
is  widely  used  and  admitted  in  the  literature  [24]. However,
increasing  the  number  of  surgical  procedures  increases  also
the  risk  of  infection  [25]. Indeed,  we  found  that  in  6.5%  of
cases  (3/46),  although  the  initial  infection  was  controlled  a
new  infection  occurred  with  a  different  germ.
There  was  no  signiﬁcant  difference  in  success  rate
between  the  two  groups,  but  there  was  no  re-infection  in
the  one-stage  group.  However,  the  surgical  procedure  was
more  complicated  in  the  two-stage  group,  with  more  severe
bone  loss.  Furthermore,  these  patients  had  a  higher  rate  of
previous  hip  surgery,  which  is  known  to  be  correlated  to  a
higher  risk  failure  to  cure  infection  [25].
For  the  two-stage  procedures,  even  though  no  antibiotic
impregnated  cement  spacer  was  used,  the  initial  infec-
tion  was  controlled  in  more  than  97%  of  cases,  and  91.3%
of  patients  had  no  infection  at  follow  up.  These  results
are  similar  to  those  reported  in  the  literature,  especially
when  compared  with  the  success  rate  reported  by  authors
using  antibiotic  impregnated  cement  spacer  [26]. To  our
knowledge,  there  is  no  reported  study  comparing  among
a  large  cohort,  two  groups  of  patients  who  underwent  a
two-stage  procedure  using  even  a  normal  cement  spacer  or
an  antibiotic-loaded  cement  spacer.  In  fact,  Cabrita  et  al.
[26]  compared  patients  with  a  spacer  and  patients  with  no
spacer,  so  there  was  not  only  the  antibiotic  factor  but  also
the  stabilisation  of  the  hip.
At  the  time  of  the  re-implantation  in  the  two-stage  group,
germs  were  found  in  37%  of  cases  despite  the  fact  that  a
pre-operative  hip  aspiration  was  found  negative.  This  lak
of  value  of  the  hip  aspiration  before  the  second  stage  has
to  be  kept  in  mind.  Some  authors  proposed  to  perform
intra-operative  frozen  section  in  order  to  decide  of  the  re-
implantation  [27].
The  main  limitation  of  the  present  study  was  that  the
patients  were  not  randomized  for  the  surgical  technique.
[149
owever,  the  aim  was  to  validate  the  hypothesis  that  the
ne-stage  procedure  was  a  successful  technique  with  no  loss
f  chance  for  the  patients  if  some  selection  criteria  were
espected.
onclusion
he  one-stage  procedure  was  found  to  be  a  successful  surgi-
al  procedure  to  treat  THA  infection  provided  that  selection
riteria  were  fulﬁlled  (germ  known  preoperatively  and  minor
one  loss).  This  decision  tree  may  help  optimize  the  treat-
ent  and  minimize  the  global  cost  with  no  loss  of  chance
or  the  patient.
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